[HTML][HTML] Serum apolipoprotein E and other inflammatory markers can identify non-responding patients to a dendritic cell vaccine
H Leeman, E Kaminska, D Green… - Translational …, 2019 - Elsevier
BACKGROUND: Despite the majority of patients do not gain any benefit from dendritic cells
(DC) vaccines, this approach has occasionally given rise to dramatic responses in …
(DC) vaccines, this approach has occasionally given rise to dramatic responses in …
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine
H Leeman, E Kaminska, D Green… - Translational …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Despite the majority of patients do not gain any benefit from dendritic cells (DC)
vaccines, this approach has occasionally given rise to dramatic responses in melanoma …
vaccines, this approach has occasionally given rise to dramatic responses in melanoma …
[PDF][PDF] Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine1, 2
Translational Oncology, 2019 - core.ac.uk
BACKGROUND: Despite the majority of patients do not gain any benefit from dendritic cells
(DC) vaccines, this approach has occasionally given rise to dramatic responses in …
(DC) vaccines, this approach has occasionally given rise to dramatic responses in …
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine.
H Leeman, E Kaminska, D Green… - Translational …, 2018 - europepmc.org
Background Despite the majority of patients do not gain any benefit from dendritic cells (DC)
vaccines, this approach has occasionally given rise to dramatic responses in melanoma …
vaccines, this approach has occasionally given rise to dramatic responses in melanoma …
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine.
H Leeman, E Kaminska, D Green… - Transl …, 2019 - openaccess.sgul.ac.uk
BACKGROUND: Despite the majority of patients do not gain any benefit from dendritic cells
(DC) vaccines, this approach has occasionally given rise to dramatic responses in …
(DC) vaccines, this approach has occasionally given rise to dramatic responses in …
[HTML][HTML] Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine
H Leeman, E Kaminska, D Green… - Translational …, 2019 - ncbi.nlm.nih.gov
BACKGROUND: Despite the majority of patients do not gain any benefit from dendritic cells
(DC) vaccines, this approach has occasionally given rise to dramatic responses in …
(DC) vaccines, this approach has occasionally given rise to dramatic responses in …
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine.
H Leeman, E Kaminska, D Green… - Transl …, 2019 - openaccess.sgul.ac.uk
BACKGROUND: Despite the majority of patients do not gain any benefit from dendritic cells
(DC) vaccines, this approach has occasionally given rise to dramatic responses in …
(DC) vaccines, this approach has occasionally given rise to dramatic responses in …
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine.
H Leeman, E Kaminska, D Green… - Translational …, 2018 - europepmc.org
Background Despite the majority of patients do not gain any benefit from dendritic cells (DC)
vaccines, this approach has occasionally given rise to dramatic responses in melanoma …
vaccines, this approach has occasionally given rise to dramatic responses in melanoma …